CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,292 enrolled
Drug / intervention
PCI using 2nd generation drug-eluting stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02715518
NCT02715518N/ACompleted

Comparison of Clinical Outcomes Between Fractional Flow Reserve-guided Strategy and Angiography-guided Strategy in Treatment of Non-Infarction Related Artery Stenosis in Patients With Acute Myocardial Infarction

Samsung Medical Center·interventional·Posted Mar 22, 2016·Updated Apr 17, 2024

In Brief

A clinical study evaluating PCI using 2nd generation drug-eluting stent for Acute Myocardial Infarction. Completed, enrolled 1,292 participants across 1 site.

Detailed Summary

The aim of the study is to compare clinical outcomes following fractional flow reserve (FFR)-guided versus angiography only guided strategy in treatment of non-infarction related artery (non-IRA) stenosis in patients with acute myocardial infarction (AMI) with multivessel disease Prospective, open-label, randomized, multicenter trial to test the clinical outcomes following FFR-guided or angiography-guided strategy in treatment of non-IRA stenosis in patients with acute AMI with multivessel disease.

Study Details

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 22, 2016
Enrollment StartAug 19, 2016
Primary CompletionJun 30, 2022
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 10.3 years ago

Interventions

PCI using 2nd generation drug-eluting stentdevice

Percutaneous coronary intervention (PCI) using 2nd generation drug-eluting stent for non-IRA stenosis will be decided according to the allocated arms. 1. FFR-guided strategy arm 2. Angiography-guided strategy arm